Good Works [CIFRW] vs Morgan Stanley [MS] Detailed Stock Comparison
Good Works
NASDAQ
Loading...
Morgan Stanley
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Good Works wins in 4 metrics, Morgan Stanley wins in 8 metrics, with 0 ties. Morgan Stanley appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Good Works | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 15.91 | N/A |
| Price-to-Book Ratio | 0.38 | 2.33 | Good Works |
| Debt-to-Equity Ratio | 25.28 | 416.64 | Good Works |
| PEG Ratio | N/A | 17.71 | N/A |
| EV/EBITDA | 54.41 | N/A | N/A |
| Profit Margin (TTM) | -96.95% | 22.49% | Morgan Stanley |
| Operating Margin (TTM) | -67.57% | 34.12% | Morgan Stanley |
| EBITDA Margin (TTM) | N/A | 34.12% | N/A |
| Return on Equity | -21.39% | 12.14% | Morgan Stanley |
| Return on Assets (TTM) | -7.68% | 1.05% | Morgan Stanley |
| Free Cash Flow (TTM) | $-391.39M | $-2.10B | Good Works |
| Dividend Yield | N/A | 2.15% | N/A |
| 1-Year Return | -40.77% | 51.16% | Morgan Stanley |
| Price-to-Sales Ratio (TTM) | 1.79 | 3.42 | Good Works |
| Enterprise Value | $320.91M | $135.62B | Morgan Stanley |
| EV/Revenue Ratio | 2.12 | 2.07 | Morgan Stanley |
| Gross Profit Margin (TTM) | 40.36% | N/A | N/A |
| Revenue per Share (TTM) | $0 | $41 | Morgan Stanley |
| Earnings per Share (Diluted) | N/A | $8.83 | N/A |
| Beta (Stock Volatility) | N/A | 1.32 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Good Works vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Good Works | 5.01% | -18.09% | -41.22% | 79.07% | -52.76% | -42.11% |
| Morgan Stanley | 1.60% | 2.94% | 1.45% | 17.48% | 4.27% | 14.75% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Good Works | -40.77% | 156.67% | -98.42% | -99.03% | -97.88% | -97.88% |
| Morgan Stanley | 51.16% | 56.21% | 173.77% | 276.29% | 452.82% | 170.92% |
Performance & Financial Health Analysis: Good Works vs Morgan Stanley
| Metric | CIFRW | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $270.10M | $224.22B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 286,209 | 4,940,340 |
| 90 Day Avg. Volume | 253,000 | 5,738,320 |
| Last Close | $0.77 | $143.18 |
| 52 Week Range | $0.32 - $1.74 | $92.78 - $145.48 |
| % from 52W High | -55.63% | -1.58% |
| All-Time High | $93.90 (Nov 15, 2021) | $145.48 (Jul 30, 2025) |
| % from All-Time High | -99.18% | -1.58% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.11% |
| Quarterly Earnings Growth | 0.02% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.97% | 0.22% |
| Operating Margin (TTM) | -0.68% | 0.34% |
| Return on Equity (TTM) | -0.21% | 0.12% |
| Debt to Equity (MRQ) | 25.28 | 416.64 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.94 | $60.41 |
| Cash per Share (MRQ) | $0.16 | $343.53 |
| Operating Cash Flow (TTM) | $-48,569,000 | $47.06B |
| Levered Free Cash Flow (TTM) | $-44,635,000 | $12.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.15% |
| Last 12-Month Dividend | $0.00 | $2.79 |
Valuation & Enterprise Metrics Analysis: Good Works vs Morgan Stanley
| Metric | CIFRW | MS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 15.91 |
| Forward P/E | N/A | 17.71 |
| PEG Ratio | N/A | 17.71 |
| Price to Sales (TTM) | 1.79 | 3.42 |
| Price to Book (MRQ) | 0.38 | 2.33 |
| Market Capitalization | ||
| Market Capitalization | $270.10M | $224.22B |
| Enterprise Value | $320.91M | $135.62B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.12 | 2.07 |
| Enterprise to EBITDA | 54.41 | N/A |
| Risk & Other Metrics | ||
| Beta | N/A | 1.32 |
| Book Value per Share (MRQ) | $1.94 | $60.41 |
Financial Statements Comparison: Good Works vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CIFRW | MS |
|---|---|---|
| Revenue/Sales | $48.96M | $16.52B |
| Cost of Goods Sold | $29.20M | N/A |
| Gross Profit | $19.76M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-32.14M | N/A |
| EBITDA | $6.43M | N/A |
| Pre-Tax Income | $-38.83M | $5.54B |
| Income Tax | $144,000 | $1.17B |
| Net Income (Profit) | $-38.98M | $4.37B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CIFRW | MS |
|---|---|---|
| Cash & Equivalents | $23.17M | $60.84B |
| Total Current Assets | $154.56M | N/A |
| Total Current Liabilities | $138.74M | N/A |
| Long-Term Debt | $15.82M | $303.93B |
| Total Shareholders Equity | $734.80M | $107.85B |
| Retained Earnings | $-220.39M | $107.65B |
| Property, Plant & Equipment | $40.97M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CIFRW | MS |
|---|---|---|
| Operating Cash Flow | $-43.82M | $-67.29B |
| Capital Expenditures | $-99.68M | $-713.00M |
| Free Cash Flow | $-147.27M | $-24.69B |
| Debt Repayment | $-911,000 | $-20.85B |
| Common Stock Repurchase | $-1.14M | $-2.03B |
Short Interest & Institutional Ownership Analysis
| Metric | CIFRW | MS |
|---|---|---|
| Shares Short | N/A | 14.94M |
| Short Ratio | N/A | 2.51 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 286,209 | 4,940,340 |
| Average Daily Volume (90 Day) | 253,000 | 5,738,320 |
| Shares Outstanding | 350.78M | 1.61B |
| Float Shares | 279.91M | 1.22B |
| % Held by Insiders | N/A | 0.24% |
| % Held by Institutions | N/A | 0.63% |
Dividend Analysis & Yield Comparison: Good Works vs Morgan Stanley
| Metric | CIFRW | MS |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $2.79 |
| Last 12-Month Dividend Yield | N/A | 2.15% |
| 3-Year Avg Annual Dividend | $0.00 | $3.10 |
| 3-Year Avg Dividend Yield | N/A | 0.90% |
| 3-Year Total Dividends | $0.00 | $9.31 |
| Ex-Dividend Date | N/A | Jan 31, 2025 |